Co-Administration of Remdesivir and Azithromycin May Protect against Intensive Care Unit Admission in COVID-19 Pneumonia Requiring Hospitalization: A Real-Life Observational Study

The benefits of remdesivir treatment, with or without co-administration of antibiotics such as azithromycin, are uncertain in COVID-19 pneumonia. The aim of this retrospective single-center study was to assess the effects of remdesivir, with or without azithromycin, on hospital mortality, intensive...

Descripción completa

Detalles Bibliográficos
Autores principales: Ticinesi, Andrea, Tuttolomondo, Domenico, Nouvenne, Antonio, Parise, Alberto, Cerundolo, Nicoletta, Prati, Beatrice, Zanichelli, Ilaria, Guerra, Angela, Gaibazzi, Nicola, Meschi, Tiziana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311950/
https://www.ncbi.nlm.nih.gov/pubmed/35884195
http://dx.doi.org/10.3390/antibiotics11070941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311950/
https://www.ncbi.nlm.nih.gov/pubmed/35884195
http://dx.doi.org/10.3390/antibiotics11070941

Ejemplares similares